A Multicenter, Single-Blind, Active and Placebo-Controlled, Parallel-Group, Randomized Study of Two Dosing Regimens of Enteric Coated Sevelamer in Patients With Mild to Moderate Hypercholesterolemia.
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2013
At a glance
- Drugs Sevelamer (Primary) ; Colesevelam
- Indications Hypercholesterolaemia
- Focus Adverse reactions; Therapeutic Use
- Acronyms ELLS
- Sponsors Genzyme Corporation
- 02 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Aug 2008 Status changed from initiated to recruiting (information from ClinicalTrials.gov).
- 01 Jul 2008 New trial record.